Abstract:Exposure to nanoparticles (NPs) is frequently associated with adverse cardiovascular effects. In contrast, NPs in nanomedicine hold great promise for precise lung-specific drug delivery, especially considering the extensive pulmonary capillary network that facilitates interactions with bloodstream-suspended particles. Therefore, exact knowledge about interactions and effects of engineered NPs with the pulmonary microcirculation are instrumental for future application of this technology in patients. To unravel the real-time dynamics of intravenously delivered NPs and their effects in the pulmonary microvasculature, we employed intravital microscopy of the mouse lung. PEG amine-modified quantum dots (aQDs) with a low potential for biomolecule and cell interactions and carboxyl-modified quantum dots (cQDs) with a high interaction potential were used, representing two different NP subtypes. Only aQDs triggered rapid neutrophil recruitment in microvessels and their subsequent recruitment to the alveolar space. Application of specific inhibitors revealed that the aQDs induced neutrophil recruitment was linked to cellular degranulation, TNF-α, and DAMP release into the circulation, particularly extracellular ATP (eATP). Stimulation of the ATP-gated P2X7R induced the expression of E-selectin on microvascular endothelium with the subsequent E-selectin depended neutrophilic immune response. Leukocyte integrins (LFA-1 and MAC-1) mediated adhesion and reduction in neutrophil crawling velocity on the vascular surface. In summary, this study unravels the complex cascade of neutrophil recruitment during NP-induced sterile inflammation. Thereby we demonstrate novel adverse effects for NPs in the pulmonary microcirculation and provide critical insights for optimizing NP-based drug delivery and therapeutic intervention strategies, to ensure their efficacy and safety in clinical applications.

Nanoparticles for stimulation of neutrophil extracellular trap‐mediated immunity

Formation of aggregated neutrophil extracellular traps in tissues is determining the efficacy of particulate nanoadjuvants

Neutrophil‐Based Delivery Systems for Nanotherapeutics

The Recognition of and Reactions to Nucleic Acid Nanoparticles by Human Immune Cells

Nanoparticle-neutrophils interactions for autoimmune regulation

Usage of Nanoparticles to Alter Neutrophils' Function for Therapy.

A Nano-Immunotraining Strategy to Enhance the Tumor Targeting of Neutrophils Via in Vivo Pathogen-Mimicking Stimulation

Biological Nanoparticles in Vaccine Development

Gold nanoparticles synergize with bacterial lipopolysaccharide to enhance class A scavenger receptor dependent particle uptake in neutrophils and augment neutrophil extracellular traps formation

Nanoparticles in Subunit Vaccines: Immunological Foundations, Categories, and Applications

The type of adjuvant strongly influences the T-cell response during nanoparticle-based immunization

Adjuvant physiochemistry and advanced nanotechnology for vaccine development

Nanomaterials trigger functional responses in primary human immune cells

De Novo Chemoattractants Form Supramolecular Hydrogels for Immunomodulating Neutrophils in Vivo

Self-Assembled Proteinaceous Nanoparticles for Co-Delivery of Antigens and Cytosine Phosphoguanine (CpG) Adjuvants: Implications for Nanovaccines

Turning the Old Adjuvant from Gel to Nanoparticles to Amplify CD8 + T Cell Responses

Distinct pathways of humoral and cellular immunity induced with the mucosal administration of a nanoemulsion adjuvant

Uptake Quantification of Antigen Carried by Nanoparticles and Its Impact on Carrier Adjuvanticity Evaluation

Nanotechnology-Assisted Immunoengineering for Cancer Vaccines

eATP/P2X7R axis drives nanoparticle induced neutrophil recruitment in the pulmonary microcirculation

Nucleic acid nanoparticles (NANPs) as molecular tools to direct desirable and avoid undesirable immunological effects